Live Markets »News & Advice»Market News»Market News Details
Market News Details
Back

Drug maker Lupin receives three observations from US health regulator

Press Trust of India/New Delhi 15 May 19 | 05:31 PM

Drug maker Lupin Wednesday said it has received three observations from the US health regulator for its Aurangabad-based manufacturing facility.

The US Food and Drug Administration (USFDA) carried out the inspection at the plant from May 6 to May 15, Lupin said in a statement.

Related Stories

    No Related Stories Found
Widgets Magazine

"The inspection at the Aurangabad facility closed with three observations. The company is confident of addressing them satisfactorily," it added.

Shares of Lupin ended 3.22 per cent lower at Rs 783.10 apiece on wednesday.

Widgets Magazine

Sensex

Company Price Gain (%)
NTPC129.852.20
Coal India221.950.68
TCS2,076.950.55
O N G C144.100.42
Power Grid Corpn205.900.27

Poll

Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine